Oral Therapy and Adherence in Lymphoma

Podcast: Living with Lymphoma Home Oral Therapy and Adherence in Lymphoma An increasing number of lymphoma and chronic lymphocytic Disease generally characterized by the overproduction of abnormal or immature white blood cells that circulate or are present in the blood. (CLL) patients receive their Treatment with drugs to stop the growth of rapidly dividing cancer cells, including lymphoma cells. not from Through the vein. More treatments administered in a hospital or clinic, but via a pill, taken at home on a regular basis. These oral therapies have become a more standard part of patient care, and for a growing number of patients, oral therapies are their only option. Living with Lymphoma hosts, Victor Gonzalez and Izumi Nakano, sat down with LRF Lymphoma Scientific Research Mentoring Program grantee, Craig Portell, MD (University of Virginia) who explained oral therapies and its use for the treatment of certain types of lymphoma. They were joined by chronic lymphocytic Disease generally characterized by the overp